SYRE – spyre therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Spyre Therapeutics (SYRE) Valuation Check After Strong Recent Share Price Performance [Yahoo! Finance]
Spyre Therapeutics (NASDAQ:SYRE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $70.00 price target on the stock.
Wall Street Bullish on Spyre Therapeutics, Inc. (SYRE) with Strong Buy Rating [Yahoo! Finance]
Spyre Therapeutics Poised for Transformational 2026 With Six Expected Proof-of-Concept Readouts Beginning in Q2 [Yahoo! Finance]
Spyre Therapeutics Poised for Transformational 2026 With Six Expected Proof-of-Concept Readouts Beginning in Q2
Form 4 Spyre Therapeutics, Inc. For: Jan 09 Filed by: Burrows Scott L
Form 4 Spyre Therapeutics, Inc. For: Jan 09 Filed by: Sloan Sheldon
Form 4 Spyre Therapeutics, Inc. For: Jan 09 Filed by: Turtle Cameron
Form 4 Spyre Therapeutics, Inc. For: Jan 09 Filed by: King-Jones Heidy
Form 8-K Spyre Therapeutics, Inc. For: Jan 12
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.